Literature DB >> 30673551

When to Start Levodopa Therapy for Parkinson's Disease.

Susan Bressman1, Rachel Saunders-Pullman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30673551     DOI： 10.1056/NEJMe1814611

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  The effect and safety of levodopa alone versus levodopa sparing therapy for early Parkinson's disease: a systematic review and meta-analysis.

Authors:  Yu-Tong Zhao; Li Liu; Yong Zhao; Zong-Yi Xie
Journal:  J Neurol       Date:  2021-10-15       Impact factor: 4.849

2.  Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.

Authors:  Can Cui; Yingying Han; Hongxia Li; Hongxiang Yu; Bei Zhang; Gang Li
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

Review 3.  A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice.

Authors:  Javier Pagonabarraga; José Matías Arbelo; Francisco Grandas; Maria-Rosario Luquin; Pablo Martínez Martín; Mari Cruz Rodríguez-Oroz; Francesc Valldeoriola; Jaime Kulisevsky
Journal:  Brain Sci       Date:  2020-03-18

4.  Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease.

Authors:  Zhan-Miao Yi; Sarah Willis; Yuan Zhang; Na Liu; Qi-Yu Tang; Suo-Di Zhai
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.